Company overview
Protheragen-ING supplies active pharmaceutical ingredients (APIs) for anti-tumor, hypoglycemic, antipsychotic, bronchiectasis, and antihypertensive applications, alongside pharmaceutical excipients, intermediates, and veterinary products. It offers AI-powered drug discovery services including target identification, candidate optimization, drug repositioning, high-throughput screening, and AI synthesizers for small molecules and antibody drug conjugates. Additionally, Protheragen-ING Lab provides GLP-compliant lab synthesis, testing, medical device safety, biocompatibility, and validation services for pharmaceutical and biotech industries.
Protheragen is listed in the NovaPharmaNews Supplier Hub as a CDMO & Manufacturing partner serving United States & Americas. Core focus areas include protheragen-ing, apis supplier, ai drug discovery, glp testing, medical device services, pharma excipients.
Industry categories: CDMO & Manufacturing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.protheragen.com
- Categories
- CDMO & Manufacturing
- Markets served
- United States & Americas
- Keywords
- protheragen-ing, apis supplier, ai drug discovery, glp testing, medical device services, pharma excipients
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What APIs does Protheragen-ING supply?
- Protheragen-ING supplies hundreds of APIs including anti-tumor (e.g., enzalutamide, olaparib), hypoglycemic, antipsychotic for schizophrenia and bipolar, bronchiectasis (e.g., umeclidinium bromide), and antihypertensive APIs like ACE inhibitors and beta blockers.
- What AI drug discovery capabilities does Protheragen-ING offer?
- Protheragen-ING provides AI-powered services for target identification, drug candidate screening and optimization, drug repositioning/repurposing, high-throughput screening, and AI synthesizers for small molecule drugs and antibody drug conjugates.
- What regulatory-compliant services does Protheragen-ING Lab provide?
- Protheragen-ING Lab, a GLP service provider, offers medical device safety testing, biocompatibility testing, validation/verification, reusable device testing, lab synthesis, and drug analysis services to meet regulatory requirements.
Related editorial coverage
- Verge Rebrands AI Drug Discovery After Trial Setback
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
Explore lab tools and QA/QC resources for R&D teams.
